Standard Drug Discovery and Development

$1 to $2 billion

Cost of a new drug development

10 to 15 years

To develop a new drug

1:10k

Success rate

We can reduce those numbers to

$250k – $50M

Cost of a new drug development

4 to 5 years

To develop a new drug

3:10

Success rate

OUR APPROACH

Artificial Intelligence

Propietary Databases of Chemical Structures

Scientific Expertise

Learn about our Unique Approach

Our Directions of Work

Proprietary pipeline

Proprietary pipeline

PARTNERSHIP

Our performance indicators

12%

of our performed projects have
reached Clinical Phase 2

 

29%

of our projects have a positive
  in vitro lead

We cooperate with

LATEST NEWS

SOM Biotech strengthens its management team
April 8, 2020

SOM Biotech strengthens its management team with the appointment of Catherine Scart as Chief Medical Officer and Kevin McAllister as Chief Scientific Officer. Therefore, Catherine Scart MD will join SOM Biotech management team as Chief Medical Officer and will assume responsibility for the company´s clinical trials and lead the pipeline ...

SOM Biotech at the Eyeforpharma Barcelona Virtual
March 26, 2020

SOM Biotech will attend the Eyeforpharma Barcelona event that will be hosted online due to the impact of COVID-19, between March 31st and April 2nd 2020. Maria Zimina – Business Development Manager – underlines: “We look forward to having the opportunity to share and discuss with potential business partners and ...

SOM Biotech encourages you to stay at home to face the COVID-19 pandemic
March 18, 2020

At SOM Biotech we want to encourage you to stay at home and protect the most vulnerable people in the face of the COVID-19 pandemic, such as the elderly and those who have chronic and rare diseases with difficult treatment. Like thousands of professionals in the biopharmaceutical and healthcare sector, ...

Rare Disease Day 2020
SOM Biotech participates in the Rare Disease Day event 2020 ”We are the 300 million”
February 26, 2020

SOM Biotech will participate in the Rare Disease Day event organized by the Catalan rare disease association “Plataforma Malalties Minoritaires”, with the slogan “We are the 300 million” that will take place on February 28th in Barcelona. The Rare Disease Day event will be focused on expert discussion tables chaired ...

Top Spanish Start-ups to follow in 2020
SOM Biotech is one of the Top Spanish Start-ups to follow in 2020
January 31, 2020

SOM Biotech is one of the Top Spanish Start-ups to follow in 2020 according to Sifted. Since its foundation in 2009, SOM Biotech stands out for its dynamism, its scientific rigor, and its innovative spirit. As an AI drug discovery company, SOM Biotech has developed more than 50 projects, has licensed ...

SOM Biotech achieves relevant advances in its pipeline leveraging on its proprietary AI based drug discovery technology SOM[AI]- PRO
January 28, 2020

SOM Biotech closes a remarkable year, achieving relevant advances in its drug development pipeline. Leveraging on its proprietary AI-based drug discovery technology SOMAI-PRO. According to Raul Insa – CEO of SOM Biotech – “ 2019 has been a great year, in which we have achieved major milestones in our pipeline ...

SOM Biotech at the Invest Securities Biomed Event
January 28, 2020

SOM Biotech attends the Invest Securities Biomed Event on January 28th in Paris. Raul Insa – CEO of SOM Biotech – participates in “one to one” meetings with international institutional investors. Therefore, according to Dr. Insa: “we will have the opportunity to share with qualified investors SOM´s future strategic growth ...

Biomedical companies rise 60 million in investment rounds – Press release EXPANSIÓN Catalunya
January 24, 2020

The Catalan Biotechnology and digital health companies dedicated to biomedicine and digital health captured 59.8 million euros in 2019 in financing rounds, 4.9% more than in 2018, when the investment volume reached 57 million, according to the ranking elaborated by EXPANSIÓN Catalunya. SOM Biotech is in third place on the ...